Rain Oncology Inc. (NASDAQ:RAIN) Receives Average Rating of Hold from Analysts

Shares of Rain Oncology Inc. (NASDAQ:RAIN – Get Free Report) have been assigned a consensus rating of “Hold” from the twelve ratings firms that are covering the firm, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average […]

Related Keywords

United States ,America ,Kevinc Tang , ,America Corp ,Securities Exchange Commission ,Rain Oncology Inc ,Morgan Stanley ,Goldman Sachs Group Inc ,Millennium Management ,Renaissance Technologies ,Nasdaq ,Rain Oncology ,Get Free Report ,Marketbeat Ratings ,Exchange Commission ,Sachs Group ,Get Free ,Oncology Inc ,Rain Oncology Daily ,Nasdaq Rain ,Rain ,Medical ,Ratings ,Consensus ,